Zimmer Biomet Shoulder Arthroplasty PMCF Study
NCT: NCT06920459 · RECRUITING
Brief Summary
This is a multicenter, prospective, non-controlled post market surveillance study. The objectives of this study are to confirm the safety, performance, and clinical benefits of the Zimmer Biomet Shoulder Arthroplasty systems in primary anatomic shoulder arthroplasty and its instrumentation. Safety of the systems will be assessed by monitoring the frequency and incidence of adverse events. The performance and clinical benefits will be evaluated by assessment of the overall pain and functional performance, qualify of life, and radiographic parameters of all enrolled study subjects.
Frequently Asked Questions
What is Zimmer Biomet Shoulder Arthroplasty PMCF Study?
Zimmer Biomet Shoulder Arthroplasty PMCF Study is a clinical trial registered under NCT06920459. Current status: RECRUITING.
What is the status of NCT06920459?
The current status of NCT06920459 (Zimmer Biomet Shoulder Arthroplasty PMCF Study) is: RECRUITING.
When did Zimmer Biomet Shoulder Arthroplasty PMCF Study start?
Zimmer Biomet Shoulder Arthroplasty PMCF Study started on 2025-04-29.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.